Ipamorelin vs sermorelin: which is better for anti-aging?

How the Two Peptides Actually Differ

Both peptides stimulate growth hormone release, but through different mechanisms:

Sermorelin

• Class: GHRH analog (growth hormone releasing hormone)
• Mechanism: Binds to GHRH receptors on the pituitary gland, triggering GH release
• Half-life: Very short (~10 minutes) — requires frequent dosing
• History: FDA-approved historically for pediatric GH deficiency testing; now used off-label in anti-aging

Ipamorelin

• Class: Growth hormone secretagogue (GHRP) — a ghrelin receptor agonist
• Mechanism: Binds the GHSR-1a receptor on the pituitary (same receptor ghrelin uses)
• Half-life: ~2 hours — still short, but longer than sermorelin
• Selectivity: Much more selective than older GHRPs (GHRP-2, GHRP-6) — minimal cortisol and prolactin spillover

The Key Clinical Difference

Sermorelin and ipamorelin work on different pituitary pathways, which means they are not redundant — they can complement each other. This is why modern protocols often combine ipamorelin with CJC-1295 (a long-acting GHRH analog) rather than using either alone. The combination activates both pathways simultaneously for a stronger, cleaner GH pulse.

Which Has Better Efficacy?

Head-to-head comparative data is limited, but clinical practice and mechanistic reasoning favor ipamorelin/CJC-1295 combinations over sermorelin monotherapy for most anti-aging applications:

• Ipamorelin + CJC-1295 produces larger and more sustained GH pulses
• Selectivity profile is cleaner
• Dosing frequency is lower (bedtime instead of multiple daily doses)

Sermorelin still has a role, particularly in patients who tolerate ipamorelin poorly or who have specific clinical situations favoring GHRH-only stimulation.

Side-Effect Comparison

Ipamorelin

• Generally well tolerated
• Minimal cortisol, prolactin elevation
• Occasional mild water retention early on
• Rare headache or tingling
• Appetite increase less pronounced than with GHRP-6

Sermorelin

• Injection-site reactions most common
• Occasional flushing, headache
• Less hunger stimulation than ipamorelin

Cost Comparison

• Ipamorelin (compounded): $80–$150 per 5 mg vial; typical monthly cost $80–$200
• Sermorelin (compounded): $70–$140 per vial; typical monthly cost $80–$180
• CJC-1295/Ipamorelin combo: $150–$300 per month (usually pre-mixed by the pharmacy)

The two single-peptides are similarly priced. The combination with CJC-1295 costs about $100 more per month than either alone.

Protocol Comparison

Typical Sermorelin Protocol

• 100–300 mcg subcutaneously at bedtime, 5 nights per week
• Some protocols split into morning and evening doses
• 12-week cycles

Typical Ipamorelin/CJC-1295 Protocol

• 100–300 mcg ipamorelin + 100–200 mcg CJC-1295 subcutaneously at bedtime
• 5 nights per week
• 12-week cycles with 4-week breaks

When to Choose Sermorelin Over Ipamorelin

• Patient intolerance to ipamorelin (rare)
• Specific clinical preference from provider
• Cost-sensitive situation where combining with CJC-1295 isn't feasible

When to Choose Ipamorelin (Usually with CJC-1295)

• Standard anti-aging protocols
• Athletic recovery focus
• Sleep quality goals
• Body-composition support (lean mass preservation, fat reduction)
• Patients who prefer bedtime-only dosing

Who Should Avoid Either

• Active malignancy
• Recent cancer history (under 5 years)
• Uncontrolled diabetes
• Pregnancy or breastfeeding
• Competitive athletes subject to WADA rules (both are banned)

See ipamorelin, sermorelin, and CJC-1295 guides.